FRIEDREICH ATAXIA

 

FRIEDREICH ATAXIA

 

DEFINITION:

A multisystem disorder characterized by progressive ataxia and neurologic, cardiac, musculoskeletal, and endocrine manifestations.

EPIDEMIOLOGY:

  • incidence: 1/100,000 live births
  • age of onset:
    • usually prior to 10 years of age (but as late as 16 years)
  • risk factors:
    • familial - autosomal recessive
      • chrom.#: 9q13-q21.1
      • gene: frataxin
    • clinical features similar in members of same family
    • heterozygotes are phenotypically normal

PATHOGENESIS:

  • genetic defect -> impaired expression of frataxin -> accumulation of iron within the mitochondria of affected cells -> production of free radicals within the affected cells -> cell death -> phenotypic expression in the nervous system (CNS and peripheral nerves), cardiac tissue and pancreas

CLINICAL FEATURES:

1. Neurological Manifestations

1. Ataxia

  • initial presentation in 95% of cases
  • slowly progressive -> loss of ambulation within 20 yrs

2. Cerebellar Dysfunction

  • dysarthria (explosive)
  • dysdiadokokinesia
  • finger-nose ataxia
  • tend to be more common & severe in the lower limbs than upper limbs
  • head titubation
  • ocular dysmetria
  • positive Romberg test

3. Others

1. Reflexes

  • absent deep tendon reflexes
  • extensor plantar reflex

2. Sensation

  • loss of vibration and position sense
  • impaired light touch and pain sensation

3. Others

  • normal intelligence
  • neurosensory hearing loss
  • muscle weakness in hands and feet

2. Cardiac Manifestations

1. Hypertrophic Cardiomyopathy (in 90% of patients)

  • systolic ejection murmer
  • SOBOE, palpitations, chest pain (angina)
  • arrhythmias, congestive heart failure, death

3. Musculoskeletal Manifestations

  • hammer toes
  • pes cavus (high-arched feet)
  • progressive kyphoscoliosis

4. Endocrine Manifestations

  • insulin dependent diabetes mellitus
    • onset in 3rd decade in 10-20% of patients

INVESTIGATIONS:

1. Evoked Potentials

  • abnormal auditory brainstem, spinal somatosensory, visual evoked potentials

2. EMG

  • slowed nerve conduction velocities in affected limbs

3. ECG

  • reduced T wave amplitude, RVH and/or LVH, arrhythmias

4. Imaging Studies

  • x-rays to follow musculoskeletal manifestations

5. Serum

  • abnormal glucose tolerance test, hyperglycemia

MANAGEMENT:

1. Supportive

  • no treatment available to stop progression of disease
  • symptomatic treatment of various manifestations

INTERNET LINKS:

National Ataxia Foundation
Muscular Dystrophy Association (Australia) - Friedreich's Ataxia

 

 

Pediatric Database - FRIEDREICH ATAXIA

Pediatric Organization - Pedbase [at] Gmail.com